Article

O’Shaughnessy, Megan, Piatek, Magdalena, McCarron, Pauraic, McCann, Malachy, Devereux, Michael, Kavanagh, Kevin and Howe, Orla (2022) In Vivo Activity of Metal Complexes Containing 1,10-Phenanthroline and 3,6,9-Trioxaundecanedioate Ligands against Pseudomonas aeruginosa Infection in Galleria mellonella Larvae. Biomedicines, 10 (222). pp. 1-21. ISSN 2227-9059

Gandra, Rafael M., McCarron, Pauraic, Viganor, Livia, Fernandes, Mariana Farias, Kavanagh, Kevin, McCann, Malachy, Branquinha, Marta H., Santos, Andre L. S., Howe, Orla and Devereux, Michael (2020) In vivo Activity of Copper(II), Manganese(II), and Silver(I) 1,10-Phenanthroline Chelates Against Candida haemulonii Using the Galleria mellonella Model. Frontiers in Microbiology, 11 (470). ISSN 1664-302X

Rochford, Garret, Molphy, Zara, Kavanagh, Kevin, McCann, Malachy, Devereux, Michael, Kellett, Andrew and Howe, Orla (2019) Cu(ii) phenanthroline–phenazine complexes dysregulate mitochondrial function and stimulate apoptosis. Metallomics, 12 (1). pp. 65-78. ISSN 1756-5901

Tolan, Dina, Almotairy, Awatif Rashed Z., Howe, Orla, Devereux, Michael, Montagner, Diego and Erxleben, Andrea (2019) Cytotoxicity and ROS production of novel Pt(IV) oxaliplatin derivatives with indole propionic acid. Inorganica Chimica Acta, 492. pp. 262-267. ISSN 0020-1693

Rochford, Garret, Molphy, Zara, Browne, Niall, Surlis, Carla, Devereux, Michael, McCann, Malachy, Kellett, Andrew, Howe, Orla and Kavanagh, Kevin (2018) In-vivo evaluation of the response of Galleria mellonella larvae to novel copper(II) phenanthroline-phenazine complexes. Journal of Inorganic Biochemistry, 186. pp. 135-146. ISSN 0162-0134

Kellet, Andrew, O'Connor, Mark, McCann, Malachy, Howe, Orla, Casey, Alan, McCarron, Pauraic, Kavanagh, Kevin, McNamara, Mary, Kennedy, Sean, May, Donald D., Skell, Philip S., O'Shea, Denis and Devereux, Michael (2011) Water-soluble bis(1,10-phenanthroline) octanedioate Cu2+ and Mn2+ complexes with unprecedented nano and picomolar in vitro cytotoxicity: promising leads for chemotherapeutic drug development. MedChemComm, 2 (7). pp. 579-584. ISSN 2040-2503